Tickerplace logo

Tickerplace

Liminatus Pharma, Inc. Class A Common Stock logo

LIMNLiminatus Pharma, Inc. Class A Common Stock

LIMN Stock Price, Valuation & Chart | Liminatus Pharma, Inc. Class A Common Stock

Compare
$3.840+0.20 (+5.35%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyLIMN intrinsic valueLIMN calculated fair value vs price
OverviewFinancialsDividendsRatios

LIMN Historical price chart

LIMN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization5.16M
PE Ratio-21.33
EPS-0.18
Trading Volume31.64K
Today's High/Low4.0/3.7
Dividend Yield0.00
52 Week High/Low154.5/3.42
Shares Outstanding1.34M
LIMN Financial Statement
LIMN Analyst ratings
LIMN Analysis & performance metrics

LIMN Company profile

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

LIMN Management team

Management
Chris Kim J.D., L.L.M.CEO
Chief Executive Officer, Treasurer & Secretary
Total 1 executive

LIMN Frequently asked questions

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) Stock Price?

Current stock price of Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock is $3.840. The stock price is +5.35% higher in the session. The intraday range can be seen from this page. Volume of Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock is 31.64K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock price going up or down today?

The stock price of Liminatus Pharma, Inc. Class A Common Stock (LIMN) can change with earnings, company news, and overall market sentiment. Liminatus Pharma, Inc. Class A Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Liminatus Pharma, Inc. Class A Common Stock stock expensive at its current price?

Whether Liminatus Pharma, Inc. Class A Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LIMN on this page is -21.33. EPS on this page is -0.18. Compare those figures with peers and growth expectations before deciding if the current Liminatus Pharma, Inc. Class A Common Stock price is justified.

How has the stock price of Liminatus Pharma, Inc. Class A Common Stock (LIMN) performed historically?

Historical performance for Liminatus Pharma, Inc. Class A Common Stock (LIMN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LIMN reacted to past earnings and market events.

Should I buy Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock, at this price?

Buying Liminatus Pharma, Inc. Class A Common Stock (LIMN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.